Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
- PMID: 38862008
- DOI: 10.6004/jnccn.2024.0029
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Abstract
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideration of the goals of therapy, the type and timing of prior therapy, the mutational profile of the tumor, and the differing toxicity profiles of the constituent drugs. This manuscript summarizes the data supporting the systemic therapy options recommended for metastatic CRC in the NCCN Guidelines for Colon Cancer.
Similar articles
-
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2017 Mar;15(3):370-398. doi: 10.6004/jnccn.2017.0036. J Natl Compr Canc Netw. 2017. PMID: 28275037
-
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152. doi: 10.6004/jnccn.2013.0022. J Natl Compr Canc Netw. 2013. PMID: 23411381
-
Colon cancer, version 3.2014.J Natl Compr Canc Netw. 2014 Jul;12(7):1028-59. doi: 10.6004/jnccn.2014.0099. J Natl Compr Canc Netw. 2014. PMID: 24994923
-
Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).Endokrynol Pol. 2013;64(6):494-504. doi: 10.5603/EP.2013.0032. Endokrynol Pol. 2013. PMID: 24431120
-
An overview of approaches to adjuvant therapy for colorectal cancer in the United States.Clin Colorectal Cancer. 2005 Apr;5 Suppl 1:S11-8. doi: 10.3816/ccc.2005.s.002. Clin Colorectal Cancer. 2005. PMID: 15871761 Review.
Cited by
-
In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer Syndromes.Cells. 2024 Aug 6;13(16):1314. doi: 10.3390/cells13161314. Cells. 2024. PMID: 39195204 Free PMC article. Review.
-
Recent advances in self-targeting natural product-based nanomedicines.J Nanobiotechnology. 2025 Jan 20;23(1):31. doi: 10.1186/s12951-025-03092-9. J Nanobiotechnology. 2025. PMID: 39833846 Free PMC article. Review.
-
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study.Adv Ther. 2025 Feb;42(2):1222-1236. doi: 10.1007/s12325-024-03077-4. Epub 2025 Jan 13. Adv Ther. 2025. PMID: 39804541 Free PMC article.
-
Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up.World J Gastroenterol. 2025 May 14;31(18):106670. doi: 10.3748/wjg.v31.i18.106670. World J Gastroenterol. 2025. PMID: 40496357 Free PMC article.
-
Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study.Front Pharmacol. 2025 Jul 8;16:1624322. doi: 10.3389/fphar.2025.1624322. eCollection 2025. Front Pharmacol. 2025. PMID: 40697651 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical